Analysis of expanded criteria to select candidates for active surveillance of low-risk prostate cancer

We aimed to analyze the value of each criterion for clinically insignificant prostate cancer (PCa) in the selection of men for active surveillance (AS) of low-risk PCa. We identified 532 men who were treated with radical prostatectomy from 2006 to 2013 who met 4 or all 5 of the criteria for clinical...

Full description

Bibliographic Details
Main Authors: Jung Ki Jo, Han Sol Lee, Young Ik Lee, Sang Eun Lee, Sung Kyu Hong
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-04-01
Series:Asian Journal of Andrology
Subjects:
Online Access:http://www.ajandrology.com/article.asp?issn=1008-682X;year=2015;volume=17;issue=2;spage=248;epage=252;aulast=Jo
id doaj-47a5d240cb194d05977ec944763d3c3f
record_format Article
spelling doaj-47a5d240cb194d05977ec944763d3c3f2020-11-24T22:19:03ZengWolters Kluwer Medknow PublicationsAsian Journal of Andrology1008-682X1745-72622015-04-0117224825210.4103/1008-682X.142136Analysis of expanded criteria to select candidates for active surveillance of low-risk prostate cancerJung Ki Jo Han Sol Lee Young Ik Lee Sang Eun Lee Sung Kyu HongWe aimed to analyze the value of each criterion for clinically insignificant prostate cancer (PCa) in the selection of men for active surveillance (AS) of low-risk PCa. We identified 532 men who were treated with radical prostatectomy from 2006 to 2013 who met 4 or all 5 of the criteria for clinically insignificant PCa (clinical stage ≤ T1, prostate specific antigen [PSA] density ≤ 0.15, biopsy Gleason score ≤ 6, number of positive biopsy cores ≤ 2, and no core with > 50% involvement) and analyzed their pathologic and biochemical outcomes. Patients who met all 5 criteria for clinically insignificant PCa were designated as group A (n = 172), and those who met 4 of 5 criteria were designated as group B (n = 360). The association of each criterion with adverse pathologic features was assessed via logistic regression analyses. Comparison of group A and B and also logistic regression analyses showed that PSA density > 0.15 ng ml−1 and high (≥7) biopsy Gleason score were associated with adverse pathologic features. Higher (> T1c) clinical stage was not associated with any adverse pathologic features. Although ≤ 3 positive cores were not associated with any adverse pathology, ≥4 positive cores were associated with higher risk of extracapsular extension. Among potential candidates for AS, PSA density > 0.15 ng ml−1 and biopsy Gleason score > 6 pose significantly higher risks of harboring more aggressive disease. The eligibility criteria for AS may be expanded to include men with clinical stage T2 tumor and 3 positive cores.http://www.ajandrology.com/article.asp?issn=1008-682X;year=2015;volume=17;issue=2;spage=248;epage=252;aulast=Joprediction; prostate; prostatectomy; prostatic neoplasms; risk
collection DOAJ
language English
format Article
sources DOAJ
author Jung Ki Jo
Han Sol Lee
Young Ik Lee
Sang Eun Lee
Sung Kyu Hong
spellingShingle Jung Ki Jo
Han Sol Lee
Young Ik Lee
Sang Eun Lee
Sung Kyu Hong
Analysis of expanded criteria to select candidates for active surveillance of low-risk prostate cancer
Asian Journal of Andrology
prediction; prostate; prostatectomy; prostatic neoplasms; risk
author_facet Jung Ki Jo
Han Sol Lee
Young Ik Lee
Sang Eun Lee
Sung Kyu Hong
author_sort Jung Ki Jo
title Analysis of expanded criteria to select candidates for active surveillance of low-risk prostate cancer
title_short Analysis of expanded criteria to select candidates for active surveillance of low-risk prostate cancer
title_full Analysis of expanded criteria to select candidates for active surveillance of low-risk prostate cancer
title_fullStr Analysis of expanded criteria to select candidates for active surveillance of low-risk prostate cancer
title_full_unstemmed Analysis of expanded criteria to select candidates for active surveillance of low-risk prostate cancer
title_sort analysis of expanded criteria to select candidates for active surveillance of low-risk prostate cancer
publisher Wolters Kluwer Medknow Publications
series Asian Journal of Andrology
issn 1008-682X
1745-7262
publishDate 2015-04-01
description We aimed to analyze the value of each criterion for clinically insignificant prostate cancer (PCa) in the selection of men for active surveillance (AS) of low-risk PCa. We identified 532 men who were treated with radical prostatectomy from 2006 to 2013 who met 4 or all 5 of the criteria for clinically insignificant PCa (clinical stage ≤ T1, prostate specific antigen [PSA] density ≤ 0.15, biopsy Gleason score ≤ 6, number of positive biopsy cores ≤ 2, and no core with > 50% involvement) and analyzed their pathologic and biochemical outcomes. Patients who met all 5 criteria for clinically insignificant PCa were designated as group A (n = 172), and those who met 4 of 5 criteria were designated as group B (n = 360). The association of each criterion with adverse pathologic features was assessed via logistic regression analyses. Comparison of group A and B and also logistic regression analyses showed that PSA density > 0.15 ng ml−1 and high (≥7) biopsy Gleason score were associated with adverse pathologic features. Higher (> T1c) clinical stage was not associated with any adverse pathologic features. Although ≤ 3 positive cores were not associated with any adverse pathology, ≥4 positive cores were associated with higher risk of extracapsular extension. Among potential candidates for AS, PSA density > 0.15 ng ml−1 and biopsy Gleason score > 6 pose significantly higher risks of harboring more aggressive disease. The eligibility criteria for AS may be expanded to include men with clinical stage T2 tumor and 3 positive cores.
topic prediction; prostate; prostatectomy; prostatic neoplasms; risk
url http://www.ajandrology.com/article.asp?issn=1008-682X;year=2015;volume=17;issue=2;spage=248;epage=252;aulast=Jo
work_keys_str_mv AT jungkijo analysisofexpandedcriteriatoselectcandidatesforactivesurveillanceoflowriskprostatecancer
AT hansollee analysisofexpandedcriteriatoselectcandidatesforactivesurveillanceoflowriskprostatecancer
AT youngiklee analysisofexpandedcriteriatoselectcandidatesforactivesurveillanceoflowriskprostatecancer
AT sangeunlee analysisofexpandedcriteriatoselectcandidatesforactivesurveillanceoflowriskprostatecancer
AT sungkyuhong analysisofexpandedcriteriatoselectcandidatesforactivesurveillanceoflowriskprostatecancer
_version_ 1725780373922643968